RHUMBLINE ADVISERS - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 38 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$97,000
-3.0%
13,340
+1.3%
0.00%
Q4 2020$100,000
-3.8%
13,165
+15.0%
0.00%
Q3 2020$104,000
-8.8%
11,445
-15.3%
0.00%
Q2 2020$114,000
+128.0%
13,520
+32.5%
0.00%
Q1 2020$50,000
-31.5%
10,2000.0%0.00%
Q4 2019$73,000
-32.4%
10,200
+2.0%
0.00%
Q3 2019$108,000
-17.6%
10,000
-0.7%
0.00%
Q2 2019$131,00010,0750.00%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Lion Point Capital, LP 500,000$2,290,0000.43%
Orbimed Advisors 8,466,783$38,778,0000.43%
Sio Capital Management, LLC 182,630$836,0000.27%
Eversept Partners, LP 349,919$1,602,6290.11%
SAMLYN CAPITAL, LLC 1,474,108$6,752,0000.09%
PLATINUM INVESTMENT MANAGEMENT LTD 320,273$1,467,0000.04%
PURA VIDA INVESTMENTS, LLC 245,492$1,124,0000.03%
SANDERS MORRIS HARRIS LLC 35,000$160,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 176,500$808,0000.02%
Ergoteles LLC 65,827$301,0000.01%
View complete list of LOGICBIO THERAPEUTICS INC shareholders